Amoxicillin
NDC Package 45865-594-20

11-digit billing NDC: 45865059420

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Amoxicillin is tap bottle until all powder flows freely. Marketed by Medsource Pharmaceuticals, this product is identified by NDC 45865-594 and is authorized under FDA application ANDA065228.

Identification & Billing

NDC Package Code
45865-594-20
Package Description
20 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
45865059420
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Amoxicillin
Dosage Form
-
Usage Information
Tap bottle until all powder flows freely. Add approximately 1/3 of the total amount of water for reconstitution (see Table 2) and shake vigorously to wet powder. Add remainder of the water and again shake vigorously.Table 2. Amount of Water for Mixing Oral SuspensionStrengthBottle SizeAmount of Water Required for ReconstitutionOral Suspension 125 mg/5 mL80 mL55 mL100 mL68 mL150 mL102 mLOral Suspension 200 mg/5 mL50 mL34 mL75 mL51 mL100 mL68 mLOral Suspension 250 mg/5 mL80 mL55 mL100 mL68 mL150 mL102 mLOral Suspension 400 mg/5 mL50 mL34 mL75 mL51 mL100 mL68 mLAfter reconstitution, the required amount of suspension should be placed directly on the child’s tongue for swallowing. Alternate means of administration are to add the required amount of suspension to formula, milk, fruit juice, water, ginger ale, or cold drinks. These preparations should then be taken immediately.NOTE: SHAKE ORAL SUSPENSION WELL BEFORE USING. Keep bottle tightly closed. Any unused portion of the reconstituted suspension must be discarded after 14 days. Refrigeration is preferable, but not required.

Regulatory & Marketing

Labeler Name
Medsource Pharmaceuticals
FDA Application #
ANDA065228
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-13-2005
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45865-594-20 identifies a specific commercial package of 20 tablet, film coated in 1 bottle of Amoxicillin, labeled by Medsource Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medsource Pharmaceuticals on July 13, 2005. The current certification is valid through December 31, 2022.

How is this Medsource Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45865059420. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45865-594-20
11-Digit CMS (5-4-2)
45865-0594-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.